These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3736679

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH, Braakhuis B, De Regt V, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1980 Jun 27; 64(4):349-55. PubMed ID: 7389827
    [Abstract] [Full Text] [Related]

  • 27. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH, Dvorkin B, Klein PN.
    Proc Natl Acad Sci U S A; 1982 Jul 27; 79(13):4212-6. PubMed ID: 6213964
    [Abstract] [Full Text] [Related]

  • 28. Certain dopamine agonists increase dopamine synthesis in the striatum of rat brain.
    Westerink BH, Feenstra MG, Wirix E, Horn AS.
    Eur J Pharmacol; 1984 Jun 01; 101(3-4):235-41. PubMed ID: 6432559
    [Abstract] [Full Text] [Related]

  • 29. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 01; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 30. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
    Hirschhorn ID, Makman MH.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):61-7. PubMed ID: 7128701
    [Abstract] [Full Text] [Related]

  • 31. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

  • 32. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA.
    Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944
    [Abstract] [Full Text] [Related]

  • 33. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN.
    Cell Mol Neurobiol; 1981 Jun 09; 1(2):167-74. PubMed ID: 7346167
    [Abstract] [Full Text] [Related]

  • 34. A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
    Feenstra MG, Sumners C, Goedemoed JH, de Vries JB, Rollema H, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep 09; 324(2):108-15. PubMed ID: 6646238
    [Abstract] [Full Text] [Related]

  • 35. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
    Lamont JS, Kula NS, Baldessarini RJ.
    Neuropharmacology; 1987 Jun 09; 26(6):637-9. PubMed ID: 3601010
    [Abstract] [Full Text] [Related]

  • 36. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ, Marsh ER, Kula NS, Zong RS, Gao YG, Neumeyer JL.
    Biochem Pharmacol; 1990 Aug 01; 40(3):417-23. PubMed ID: 2383279
    [Abstract] [Full Text] [Related]

  • 37. N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting properties.
    Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Horn AS.
    Eur J Pharmacol; 1985 Feb 26; 109(2):229-40. PubMed ID: 3922776
    [Abstract] [Full Text] [Related]

  • 38. [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.
    Clement-Cormier Y, Smith CE.
    Neurochem Res; 1980 Jun 26; 5(6):641-51. PubMed ID: 7402434
    [Abstract] [Full Text] [Related]

  • 39. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C, De Vries JB, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1981 Apr 09; 70(4):541-50. PubMed ID: 6113149
    [Abstract] [Full Text] [Related]

  • 40. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM, Waddington JL.
    Pharmacol Biochem Behav; 1990 Jan 09; 35(1):105-10. PubMed ID: 1969161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.